Director of Cytokinetics Inc (NASDAQ:CYTK), Henderson John T, sells 858 shares worth $17,426
According to Cytokinetics Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 31 04:55 PM, company Director, Henderson John T disclosed selling 858 shares at a cost of $20.31. At the time of this transaction (Dec 31), this trade was worth $17,426 in total. As of Dec 31, Henderson John T now owns 899 shares in total worth about $18,690.21.
For the last few recent trades made by Cytokinetics Inc (NASDAQ:CYTK) Director, Henderson John T, we have the following information:
- SEC Form 4 filing: Oct 05: Sold 3,000 shares at the rate of $29.00 per share. Total worth of this trade was $87,000. Total number of shares owned as of Oct 05 were 899
Posted by
George Daniels
on Thursday December 31 2020, 5:53 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
